TME Pharma NV (ALTME) EUR1

TME Pharma NV formerly NOXXON Pharma NV is a biotechnology company focusing on developing therapies for the treatment of cancers. The Company specializes in approaches targeting the tumor microenvironment (TME) in which cancer cells exist. Its technology breaks tumor protection barriers against the immune system and blocks tumor repair by neutralizing chemokines in the TME. TME Pharma’s approach works in combination with other forms of treatment to weaken tumor defenses and enable greater therapeutic impact. their clinical programs in glioblastoma and pancreatic cancer have delivered results and further development is planned.